La terapia antiviral reduce la dislipidemia y el riesgo cardiovascular en la hepatitis B crónica: el TDF es el agente más eficaz
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.La terapia antiviral para la hepatitis B crónica (CHB) reduce significativamente el riesgo de dislipidemia y de eventos cardiovasculares adversos mayores (MACE). El fumarato de tenofovir disoproxil (TDF) ofrece la protección más sustancial, destacando los beneficios extrahepáticos más allá de la supresión viral.
Área De La Ciencia
- Hepatología
- Cardiología
- Síndrome metabólico
Sus Antecedentes
- La hepatitis B crónica requiere tratamiento antiviral a largo plazo.
- No se comprende completamente el impacto de la terapia antiviral con CHB en la salud metabólica y cardiovascular.
Objetivo Del Estudio
- Investigar los efectos de la terapia antiviral en la dislipidemia y los eventos adversos cardiovasculares mayores (EACM) en pacientes con EHC.
- Evaluar los beneficios específicos del fumarato de tenofovir disoproxilo (TDF).
Principales Métodos
- Estudio de cohorte retrospectivo a nivel nacional utilizando datos de la revisión y evaluación del seguro de salud coreano.
- Coincidencia de la puntuación de propensión entre 48.606 pacientes tratados con CHB y controles no tratados.
- Análisis de las tasas de incidencia y de los ratios de riesgo para la dislipidemia y la EMA.
Principales Resultados
- La terapia antiviral redujo significativamente las tasas de incidencia de dislipidemia (IRR: 0,80) y de MACE (IRR: 0,78).
- El fumarato de tenofovir disoproxil (TDF) demostró los efectos protectores más fuertes (aHR: 0,52 para la dislipidemia, 0,58 para el MACE).
- Los efectos protectores fueron más pronunciados en pacientes no diabéticos.
Conclusiones
- La terapia antiviral para CHB ofrece beneficios extrahepáticos significativos, incluido el riesgo reducido de dislipidemia y MACE.
- El TDF es particularmente eficaz para mitigar estos riesgos.
- Estos hallazgos apoyan el uso de la terapia antiviral en el tratamiento integral a largo plazo de la EHC.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...